This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

P3 Prostate Cancer Forum: 2024

Session 4 - Looking ahead: confronting the challenges of mCRPC

P3 background - Article

In session 4, we took a deep dive into mCRPC; the latest therapies, data and key considerations for treatment sequencing in this patient group

Beyond ARIs and chemotherapy: Exploring New Horizons in mCRPC treatment – Dr Elena Castro
Speakers
    • Dr Elena Castro
      Dr Elena Castro
      Consultant Medical Oncologist, Virgen de la Victoria University Hospital in Malaga, Spain
Are you interested in P3 2025?

Register your interest to attend either virtually or in-person for 2025's meeting.

PP-NUB-GB-2019, January 2025